KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Inventory (2016 - 2026)

Boston Scientific's Inventory history spans 18 years, with the latest figure at $3.1 billion for Q1 2026.

  • On a quarterly basis, Inventory rose 8.72% to $3.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.1 billion, a 8.72% increase, with the full-year FY2025 number at $2.9 billion, up 4.73% from a year prior.
  • Inventory hit $3.1 billion in Q1 2026 for Boston Scientific, up from $2.9 billion in the prior quarter.
  • Over the last five years, Inventory for BSX hit a ceiling of $3.1 billion in Q1 2026 and a floor of $1.7 billion in Q1 2022.
  • Historically, Inventory has averaged $2.5 billion across 5 years, with a median of $2.6 billion in 2024.
  • Biggest five-year swings in Inventory: surged 34.45% in 2023 and later increased 4.73% in 2025.
  • Tracing BSX's Inventory over 5 years: stood at $1.9 billion in 2022, then soared by 33.05% to $2.5 billion in 2023, then rose by 13.12% to $2.8 billion in 2024, then grew by 4.73% to $2.9 billion in 2025, then rose by 5.91% to $3.1 billion in 2026.
  • Business Quant data shows Inventory for BSX at $3.1 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.9 billion in Q3 2025.